Skip to Content

S13 (Erlotinib Hydrochloride 25 mg)

Pill with imprint S13 is White, Round and has been identified as Erlotinib Hydrochloride 25 mg. It is supplied by Armas Pharmaceuticals Inc..

Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for S13

Erlotinib hydrochloride 25 mg S13

Erlotinib Hydrochloride

Imprint
S13
Strength
25 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
EGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Armas Pharmaceuticals Inc.
Manufacturer
Shilpa Medicare Limited
National Drug Code (NDC)
72485-0217

Get help with Imprint Code FAQs.

Related Images for "S13"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.